Laws & Ethics

by Dennis Crouch Novartis Pharms Corp. v. Accord Healthcare, Inc. (Fed. Cir. 2022) Without any fanfare or dissent, the Federal...

The chart above shows the number of disclaimed/dedicated patents per year going back to 1995.  Every year it has been...

Question presented in Thaler v. Vidal: "Whether an artificial intelligence can be an inventor for purposes of patent law, which...

We represent businesses.That’s all we do. Oh, and we love it. We love our work. We love reviewing that lease...

Whether it be the name, logo, or both, brand recognition can be a major contributor to a company’s overall value....

by Dennis Crouch In its petition for en banc rehearing Innovation Sciences raises some great old cases.  En banc petition...

by Dennis Crouch In re Smith, 22-1301 (Fed. Cir. Sept 9, 2022) (nonprecedential).  Smith is a short opinion affirming the...

by Dennis Crouch U.S. ex rel Silbersher v. Allergan, Inc., 21-15420, — F.4th — (9th Cir. Aug. 25, 2022) Zachary...

by Dennis Crouch The Reverse Doctrine of Equivalents can shrink the scope of a patent to exclude acts literally covered...

by Dennis Crouch In Patent Law class today, we started the chapter on “disclosure” that focuses on doctrines of enablement,...